Verfügbarkeit: Vaccines for humans

Vaccines for humans: research funded by the European Union ; [seventh framework programme]

Gespeichert in:

Bibliographische Detailangaben
Format:	Regierungsdokument Buch
Sprache:	English
Veröffentlicht:	Luxembourg Office for Official Publ. of the European Communities 2008
Schriftenreihe:	European research area Project synopses
Schlagworte:	Europäische Union Forschungsprojekt Infektionskrankheit Forschungsförderung Impfstoff Verzeichnis Führer
Online-Zugang:	Volltext Inhaltsverzeichnis
Beschreibung:	167 S. Ill., graph. Darst., zahlr. Kt.
ISBN:	9789279094552

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV035215477
003	DE-604
005	20090618
007	t\|
008	081215s2008 xx abd\| \|\|\|\| 00\|\|\| eng d
020			\|a 9789279094552 \|9 978-92-79-09455-2
024	3		\|a 9789279094552
035			\|a (OCoLC)612114014
035			\|a (DE-599)BSZ288522168
040			\|a DE-604 \|b ger
041	0		\|a eng
049			\|a DE-355 \|a DE-12 \|a DE-521
084			\|a XD 3303 \|0 (DE-625)152554:12909 \|2 rvk
086			\|a KI-81-08-337-EN-C
086			\|a KI 81 08 337 EN C
245	1	0	\|a Vaccines for humans \|b research funded by the European Union ; [seventh framework programme] \|c European Commission, Directorate Health, [Unit F3 - Infectious Diseases]
264		1	\|a Luxembourg \|b Office for Official Publ. of the European Communities \|c 2008
300			\|a 167 S. \|b Ill., graph. Darst., zahlr. Kt.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a European research area
490	0		\|a Project synopses
610	2	7	\|a Europäische Union \|0 (DE-588)5098525-5 \|2 gnd \|9 rswk-swf
650	0	7	\|a Forschungsprojekt \|0 (DE-588)4155053-5 \|2 gnd \|9 rswk-swf
650	0	7	\|a Infektionskrankheit \|0 (DE-588)4026879-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Forschungsförderung \|0 (DE-588)4125049-7 \|2 gnd \|9 rswk-swf
650	0	7	\|a Impfstoff \|0 (DE-588)4026655-2 \|2 gnd \|9 rswk-swf
655		7	\|8 1\p \|0 (DE-588)4188171-0 \|a Verzeichnis \|2 gnd-content
655		7	\|8 2\p \|0 (DE-588)4155569-7 \|a Führer \|2 gnd-content
689	0	0	\|a Europäische Union \|0 (DE-588)5098525-5 \|D b
689	0	1	\|a Infektionskrankheit \|0 (DE-588)4026879-2 \|D s
689	0	2	\|a Forschungsförderung \|0 (DE-588)4125049-7 \|D s
689	0	3	\|a Impfstoff \|0 (DE-588)4026655-2 \|D s
689	0		\|8 3\p \|5 DE-604
689	1	0	\|a Europäische Union \|0 (DE-588)5098525-5 \|D b
689	1	1	\|a Infektionskrankheit \|0 (DE-588)4026879-2 \|D s
689	1	2	\|a Forschungsprojekt \|0 (DE-588)4155053-5 \|D s
689	1		\|8 4\p \|5 DE-604
710	2		\|a Europäische Kommission \|b Referat Infektionskrankheiten \|e Sonstige \|0 (DE-588)10183877-3 \|4 oth
856	4	1	\|u http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/pdf/vaccine-research-catalogue%5Fen.pdf \|x Verlag \|z kostenfrei \|3 Volltext
856	4	2	\|m Digitalisierung UB Bayreuth \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017021644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 2\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 3\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 4\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
912			\|a ebook
943	1		\|a oai:aleph.bib-bvb.de:BVB01-017021644

Datensatz im Suchindex

_version_	1820136147241664512
adam_text	TABLE OF CONTENTS COMMISSIONER'S PREFACE INTRODUCTION 14 HUMAN VACCINE RESEARCH IN THE EUROPEAN UNION 15 EUROPEAN VACCINE RESEARCH 18 INTRODUCTION BASIC VACCINOLOGY 20 MUVAPRED Mucosal Vaccines for Poverty-Related Diseases 24 EPIVAC Development of a Multi-Step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS 26 MUNANOVAC Mucosal Nano-Vaccine Candidate for HIV 28 COMPUVAC Rational Design and Standardised Evaluation of Genetic Vaccines 30 BACABS Assessment of Structural Requirements in Complement-Mediated Bactericidal Events: Towards a Global Approach to the Selection of New Vaccine Candidates 32 MICROBEARRAY Genome Scale Analysis of the Immune Response against Pathogenic Micro-Organisms Leading to Diagnostic and Vaccine Candidates and Development of an Integrated Micro Array Platform for Clinical Use 34 DEC-VAC Development of a Dendritic Cell-Targeted Vaccine against AIDS 36 DC-VACC Dendritic Cells as Natural Adjustments for Novel Vaccine Technologies 38 THERAVAC Optimised delivery system for vaccines targeted to dendritic cells 40 AIDS-COVAC Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV Model 42 HIVAB Generation of Broadly Cross-Neutralising Antibodies for Innovative Active-Passive HIV Vaccination Strategies Based on Modified Ig-Gene Transgenic Mice 44 INNOVAC Highly Innovative Strategies for Vaccination to Poverty-Related Diseases 46 IMMUNOGRID The European Virtual Human Immune System Project 48 VACCTIP Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways 50 MVACTOR Host Immune Activation-Optimised Vaccinia Virus Vectors for Vaccine Development DISEASES SPECIFIC VACCINE RESEARCH 53 INTRODUCTION DISEASE SPECIFIC VACCINE RESEARCH 56 AVIP AIDS Vaccine Integrated Project 58 RMVHIV Recombinant Measles Virus as a Vector for HIV Vaccines 60 AUTO/ALLO CELL-HIV Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated Τ Cells 62 POX-GENE A Combined Pox-Virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes 64 ALLOMICROVAC A Combined Microbicidal-lmmunising Strategy Against SIV and HIV Infection 66 VIAV Very Innovative AIDS Vaccine 68 HIV VIROSOMES Development of a New Vaccine against HIV: Virosomes Incorporating HIV Proteins 70 TIP-VAC Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS 72 EPI-VAC Identification of Novel Epitopes as HIV-1 Vaccines Candidates 74 EMVDA The European Malaria Vaccine Development Association 76 PRIBOMAL ђММса! Studies towards an Affordable, Safe and Efficacious Two-Component Paediatnc Malaria Vaccine 78 SME-MALARIA SME Led Malaria Vaccine Initiative 80 MALINV Differential Expression of Malaria Invasion-Associated Proteins in the Porozoite: Novel Vaccination Strategy 82 TB-VAC An Integrated Project for New Vaccines against Tuberculosis 86 NEOTIM Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants 88 VACCINES4TB Genome - and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis 90 IMMUNOVACTB A New Approach for Developing a Less Immunosuppressive Vaccine for Tuberculosis 92 FLUVACC Live Attenuated Replication-Defective Influenza Vaccine 94 FLUVAC Dose Sparing and Increased Immunogenicity for Vaccination against Pandemic Influenza with CoVaccine HT 96 PANFLUVAC Efficacious Vaccine Formulation System for Prophylactic Control of Influenza Pandemics 98 INTRANASAL HöVACCINE Protective Efficacy of Intranasal del NS1 (H5N1) Influenza Vaccine 100 CHIMERIC VACCINES del NS1 Virus as a Vector for Foreign Antigens 102 UNIVERSAL VACCINE Novel Antigen -Adjuvant Vehicle as an Effective Influenza Vaccine 104 HEPACIVAC New Preventative and Therapeutic Hepatitis С VaccinesiFrom Preclinical to Phase I 106 DISSECT Development of Intervention Strategies against SARS in a European-Chinese Taskforce 108 SARSVAC Immunoprevention and Immunotherapy of SARS Infection 110 SARS/FLU VACCINE Development of a Combined Influenza/SARS Vaccine 112 NOVADUCK Novel AI DIVA Recombinant Vaccines for Duck 114 AIVVACC DIAGNOSIS Vaccine, Diagnostic Test Development and Immunology Aspects of Avian nfluenza 116 SCOOTT Sustainable Control of Onchocerciasis Today and Tomorrow 118 TRANCHI Τ Cell Regulation and the Control of Helminth Infections 120 BOVAC Development of a Prophylactic Vaccine and Diagnostic Markers to Diagnose and Prevent Lyme Borreliosis Specific to Europe and North America 122 SAVIN MUCOPATH Novel Therapeutic and Prophylactic Strategies to Control Mucosa! Infections by South American Bacterial Strains 124 OMVAC Novel Prevention and Treatment Possibilities for Otitis Media through the Comprehensive Identification of Antjgenic Proteins 126 HEVAR Herpesvirus-based Vaccines against Rotavirus Infections 128 SUPASALVAC Salmonella-Free Broilers by Live Vaccine-Induced Innate Resistance to Colonisation and Invasion and Novel Methods to Eliminate Vaccine and Field Strains 130 TRYPADVAC2 Development of an "Anti-Disease" Vaccine and Diagnostic Tests for African Trypanosomosis 132 CANCERIMMUNOTHERAPY Cancer Immunology and Immunotherapy 134 DENDRITOPHAGES Therapeutic Cancer Vaccines 136 LCVAC New Vaccination Therapies for Lung Cancer 138 VITAL Development of Optimised Recombinant Idiotypic Vaccines for Subset-Specific Immunotherapy of В Cell Lymphomas 140 MIMOVAX Alzheimer's Disease-Treatment Targeting Truncated AB40/42 by Active Immunisation CLINICAL RESEARCH AND CAPACITY BUILDING 144 INTRODUCTION CLINICAL RESEARCH AND CAPACITY BUILDING 146 EDCTP European and Developing Countries Clinical Trials Partnership 148 EUROPRISE European vaccines and Microbicides Enterprise 152 DC-THERA Dendritic Cells for Novel Immunothérapies 154 ENACT European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Cancer Immunotherapy 156 ADVAC-EC Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty 158 NEUTNET Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials 160 COINFECT Malaria and Coinfection: New Insights for Malaria Control 162 EURHAVAC European Network for Harmonisation of Malaria Vaccine Development 164 PAHPV-1 HPV Pilot Action Indonesia 166 REBAVAC Novel Opportunities to Develop Vaccines to Control Antibiotic Resistant Bacteria: from the Trials Back to the Laboratory
any_adam_object	1
building	Verbundindex
bvnumber	BV035215477
classification_rvk	XD 3303
collection	ebook
ctrlnum	(OCoLC)612114014 (DE-599)BSZ288522168
discipline	Medizin
format	Government Document Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV035215477</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090618</controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">081215s2008 xx abd\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789279094552</subfield><subfield code="9">978-92-79-09455-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9789279094552</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)612114014</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BSZ288522168</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-521</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3303</subfield><subfield code="0">(DE-625)152554:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="086" ind1=" " ind2=" "><subfield code="a">KI-81-08-337-EN-C</subfield></datafield><datafield tag="086" ind1=" " ind2=" "><subfield code="a">KI 81 08 337 EN C</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccines for humans</subfield><subfield code="b">research funded by the European Union ; [seventh framework programme]</subfield><subfield code="c">European Commission, Directorate Health, [Unit F3 - Infectious Diseases]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the European Communities</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">167 S.</subfield><subfield code="b">Ill., graph. Darst., zahlr. Kt.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">European research area</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Project synopses</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsprojekt</subfield><subfield code="0">(DE-588)4155053-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4188171-0</subfield><subfield code="a">Verzeichnis</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)4155569-7</subfield><subfield code="a">Führer</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Forschungsförderung</subfield><subfield code="0">(DE-588)4125049-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Forschungsprojekt</subfield><subfield code="0">(DE-588)4155053-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Europäische Kommission</subfield><subfield code="b">Referat Infektionskrankheiten</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)10183877-3</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/pdf/vaccine-research-catalogue%5Fen.pdf</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Bayreuth</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017021644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017021644</subfield></datafield></record></collection>
genre	1\p (DE-588)4188171-0 Verzeichnis gnd-content 2\p (DE-588)4155569-7 Führer gnd-content
genre_facet	Verzeichnis Führer
id	DE-604.BV035215477
illustrated	Illustrated
indexdate	2025-01-02T11:24:54Z
institution	BVB
institution_GND	(DE-588)10183877-3
isbn	9789279094552
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-017021644
oclc_num	612114014
open_access_boolean	1
owner	DE-355 DE-BY-UBR DE-12 DE-521
owner_facet	DE-355 DE-BY-UBR DE-12 DE-521
physical	167 S. Ill., graph. Darst., zahlr. Kt.
psigel	ebook
publishDate	2008
publishDateSearch	2008
publishDateSort	2008
publisher	Office for Official Publ. of the European Communities
record_format	marc
series2	European research area Project synopses
spelling	Vaccines for humans research funded by the European Union ; [seventh framework programme] European Commission, Directorate Health, [Unit F3 - Infectious Diseases] Luxembourg Office for Official Publ. of the European Communities 2008 167 S. Ill., graph. Darst., zahlr. Kt. txt rdacontent n rdamedia nc rdacarrier European research area Project synopses Europäische Union (DE-588)5098525-5 gnd rswk-swf Forschungsprojekt (DE-588)4155053-5 gnd rswk-swf Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Forschungsförderung (DE-588)4125049-7 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf 1\p (DE-588)4188171-0 Verzeichnis gnd-content 2\p (DE-588)4155569-7 Führer gnd-content Europäische Union (DE-588)5098525-5 b Infektionskrankheit (DE-588)4026879-2 s Forschungsförderung (DE-588)4125049-7 s Impfstoff (DE-588)4026655-2 s 3\p DE-604 Forschungsprojekt (DE-588)4155053-5 s 4\p DE-604 Europäische Kommission Referat Infektionskrankheiten Sonstige (DE-588)10183877-3 oth http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/pdf/vaccine-research-catalogue%5Fen.pdf Verlag kostenfrei Volltext Digitalisierung UB Bayreuth application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017021644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	Vaccines for humans research funded by the European Union ; [seventh framework programme] Europäische Union (DE-588)5098525-5 gnd Forschungsprojekt (DE-588)4155053-5 gnd Infektionskrankheit (DE-588)4026879-2 gnd Forschungsförderung (DE-588)4125049-7 gnd Impfstoff (DE-588)4026655-2 gnd
subject_GND	(DE-588)5098525-5 (DE-588)4155053-5 (DE-588)4026879-2 (DE-588)4125049-7 (DE-588)4026655-2 (DE-588)4188171-0 (DE-588)4155569-7
title	Vaccines for humans research funded by the European Union ; [seventh framework programme]
title_auth	Vaccines for humans research funded by the European Union ; [seventh framework programme]
title_exact_search	Vaccines for humans research funded by the European Union ; [seventh framework programme]
title_full	Vaccines for humans research funded by the European Union ; [seventh framework programme] European Commission, Directorate Health, [Unit F3 - Infectious Diseases]
title_fullStr	Vaccines for humans research funded by the European Union ; [seventh framework programme] European Commission, Directorate Health, [Unit F3 - Infectious Diseases]
title_full_unstemmed	Vaccines for humans research funded by the European Union ; [seventh framework programme] European Commission, Directorate Health, [Unit F3 - Infectious Diseases]
title_short	Vaccines for humans
title_sort	vaccines for humans research funded by the european union seventh framework programme
title_sub	research funded by the European Union ; [seventh framework programme]
topic	Europäische Union (DE-588)5098525-5 gnd Forschungsprojekt (DE-588)4155053-5 gnd Infektionskrankheit (DE-588)4026879-2 gnd Forschungsförderung (DE-588)4125049-7 gnd Impfstoff (DE-588)4026655-2 gnd
topic_facet	Europäische Union Forschungsprojekt Infektionskrankheit Forschungsförderung Impfstoff Verzeichnis Führer
url	http://ec.europa.eu/research/health/infectious-diseases/neglected-diseases/pdf/vaccine-research-catalogue%5Fen.pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017021644&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT europaischekommissionreferatinfektionskrankheiten vaccinesforhumansresearchfundedbytheeuropeanunionseventhframeworkprogramme

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge